ZIM Laboratories Limited
ZIMLAB.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.06B
Close$
Share Statistics
| Market cap | $8.06 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.19 |
| Beta | 0.82 |
| Outstanding Shares | 53,549,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 183.5 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About ZIM Laboratories Limited
632 employees
CEO: Anwar Siraj Daud Established in 1984 and headquartered in Nagpur, India, ZIM Laboratories Limited operates as a global entity involved in the creation, production, and distribution of both generic pharmaceutical and nutraceutical goods. The company's pro...